Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$753M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$711M |
| 3 |
Humana
HUM
|
+$617M |
| 4 |
NextEra Energy
NEE
|
+$610M |
| 5 |
British American Tobacco
BTI
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.32B |
| 2 |
STJ
St Jude Medical
STJ
|
+$690M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$629M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$609M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$603M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.39% |
| 2 | Technology | 9.09% |
| 3 | Healthcare | 7.39% |
| 4 | Energy | 7.04% |
| 5 | Consumer Discretionary | 6.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
Exponent
EXPO
$3.24B
| $2.08M | ﹤0.01% |
69,768
-34,556
| -33% | -$1.01M |
|
3652
Glaukos
GKOS
$9.83B
| $2.08M | ﹤0.01% |
40,494
+29,035
| +253% | +$1.27M |
|
3653
Autohome
ATHM
$2.67B
| $2.08M | ﹤0.01% |
65,302
-8,816
| -12% | -$281K |
|
|
SPLK
3654
CALL
DELISTED
Splunk Inc
SPLK
| $2.07M | ﹤0.01% |
33,300
-32,100
| -49% | -$1.92M |
|
|
BLUE
3655
CALL
DELISTED
bluebird bio
BLUE
| $2.07M | ﹤0.01% |
+1,760
| New | +$1.8M |
|
|
ASB.WS
3656
DELISTED
Associated Banc-Corp Warrants
ASB.WS
| $2.07M | ﹤0.01% |
387,304
-47,700
| -11% | -$275K |
|
|
FPO
3657
DELISTED
First Potomac Realty Trust
FPO
| $2.07M | ﹤0.01% |
201,554
+78,504
| +64% | +$808K |
|
3658
CALL
FirstEnergy
FE
$28B
| $2.07M | ﹤0.01% |
65,000
+16,900
| +35% | +$521K |
|
|
MB
3659
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $2.07M | ﹤0.01% |
+75,342
| New | +$1.94M |
|
|
ELGX
3660
DELISTED
Endologix Inc
ELGX
| $2.07M | ﹤0.01% |
28,530
+21,218
| +290% | +$1.4M |
|
3661
DXP Enterprises
DXPE
$2.43B
| $2.06M | ﹤0.01% |
54,538
+1,778
| +3% | +$63.5K |
|
3662
Tetra Tech
TTEK
$8.49B
| $2.06M | ﹤0.01% |
252,715
-457,655
| -64% | -$3.79M |
|
3663
Invesco Leisure and Entertainment ETF
PEJ
$259M
| $2.06M | ﹤0.01% |
50,040
-24
| -0% | -$977 |
|
3664
PUT
McKesson
MCK
$100B
| $2.06M | ﹤0.01% |
13,900
-65,200
| -82% | -$9.55M |
|
3665
Greenlight Captial
GLRE
$552M
| $2.06M | ﹤0.01% |
93,234
-157,191
| -63% | -$3.56M |
|
|
AIMT
3666
DELISTED
Aimmune Therapeutics
AIMT
| $2.06M | ﹤0.01% |
94,774
+52,558
| +124% | +$1.08M |
|
|
BCPC
3667
Balchem Corp
BCPC
$5.38B
| $2.06M | ﹤0.01% |
24,942
-23,243
| -48% | -$1.95M |
|
3668
Rayonier Advanced Materials
RYAM
$604M
| $2.05M | ﹤0.01% |
152,313
-23,436
| -13% | -$329K |
|
|
ISEE
3669
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $2.05M | ﹤0.01% |
559,643
+404,831
| +261% | +$1.71M |
|
|
SCMP
3670
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $2.05M | ﹤0.01% |
186,013
+16,624
| +10% | +$193K |
|
|
BGFV
3671
DELISTED
Big 5 Sporting Goods
BGFV
| $2.04M | ﹤0.01% |
135,395
+15,149
| +13% | +$230K |
|
3672
PUT
Jones Lang LaSalle
JLL
$16.3B
| $2.04M | ﹤0.01% |
18,300
+15,700
| +604% | +$1.71M |
|
3673
Matsons
MATX
$6.13B
| $2.04M | ﹤0.01% |
64,240
-27,938
| -30% | -$959K |
|
|
CUB
3674
DELISTED
Cubic Corporation
CUB
| $2.04M | ﹤0.01% |
38,567
-20,710
| -35% | -$1.05M |
|
3675
CALL
Parker-Hannifin
PH
$123B
| $2.04M | ﹤0.01% |
12,700
-18,700
| -60% | -$2.84M |
|
Similar funds
Goldman Sachs's Q1 2017 Portfolio in Review
As of Q1 2017, Goldman Sachs held 7,322 positions worth $369B, up 4.2% from $354B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Goldman Sachs's Q1 2017 filing shows 455 new, 2,594 increased, 3,387 reduced and 597 closed positions. Its largest new stake was Deutsche Bank Aktiengesellschaft: 36,861,723 shares worth $87M. The largest sale was NVIDIA, an estimated $1.32B.
By sector, the portfolio is most concentrated in Financials at 9.4% of assets, down from 9.9% a quarter earlier, followed by Technology and Healthcare.
- Goldman Sachs's largest Q1 2017 buy was Deutsche Bank Aktiengesellschaft: 36,861,723 shares worth $87M.
- Goldman Sachs added most to Intuitive Surgical in Q1 2017, an estimated $753M increase.
- Goldman Sachs's biggest Q1 2017 reduction was NVIDIA, cutting an estimated $1.32B.
- Goldman Sachs fully exited St Jude Medical in Q1 2017, selling an estimated $690M.
- Goldman Sachs's ten largest holdings make up 16% of its $369B portfolio in Q1 2017.
- Goldman Sachs opened 455 new positions and closed 597 in Q1 2017.
- Goldman Sachs's portfolio value rose 4.2% quarter-over-quarter to $369B.
Based on Goldman Sachs's 13F filing for Q1 2017, filed 15 May 2017.